SRSF2 Mutations Lead to Lessened Frequency of Polycythemia in Preclinical MPN Models
The presence of mutated SRSF2 in knock-in mouse models of JAK2 V617F–driven myeloproliferative neoplasms reduced the rate of polycythemia and hampered hematopoietic progenitor functions.
Source: onclive.com